Subscribe To
Medigene ag to present at the baader investment conference 2023
Planegg/Martinsried, September 11, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an ...
September 11, 2023, 12:30 pm
Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13
Management will present and hold virtual 1-on-1 meetings with institutional investors and analysts BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) ...
September 8, 2023, 6:30 pm
Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13
BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology compa...
September 8, 2023, 2:30 pm
Imunon to host virtual r&d day on september 14th beginning at 4:00 p.m. et
Program will feature members of IMUNON executive management along with key opinion leaders in immuno-on...
September 7, 2023, 8:30 pm
Nexcella, immix biopharma subsidiary, to present at the bank of america 2023 healthcare trailblazers private company conference
LOS ANGELES, Sept. 07, 2023 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”) a clinical...
September 7, 2023, 12:41 pm
Affimed to present at the h.c. wainwright annual global investment conference
HEIDELBERG, Germany, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno...
September 7, 2023, 6:30 am
Cidara to present at the 25th annual h.c. wainwright global investment conference
SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company using its proprietary Cloudbreak® pl...
September 6, 2023, 8:05 pm
Pds biotech to participate at the h.c. wainwright 25th annual global investment conference
PRINCETON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage ...
September 6, 2023, 8:05 pm
Harpoon therapeutics abstract for hpn217 accepted for poster presentation at the 20th international myeloma society annual meeting
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage ...
September 6, 2023, 11:30 am
Lava therapeutics to participate in the h.c. wainwright 25th annual global investment conference
UTRECHT, The Netherlands and PHILADELPHIA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. ( Nasdaq: LVTX ), an ...
September 6, 2023, 7:11 am
Hookipa pharma to participate in upcoming investor conferences in september
NEW YORK and VIENNA, Austria, Sept. 06, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA'), a company developing a new class of ...
September 6, 2023, 7:01 am
Genenta to present at upcoming scientific and investor conferences
MILAN, Italy and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA) a clinical-stage ...
September 6, 2023, 7:00 am
Bolt biotherapeutics to participate in september investor conferences
REDWOOD CITY, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing no...
September 5, 2023, 4:15 pm
Eledon pharmaceuticals announces first participant dosed in phase 2 bestow trial evaluating tegoprubart for the prevention of rejection in kidney transplantation
Trial to assess potential of tegoprubart-based immunosuppression to improve graft function compared to ...
September 5, 2023, 11:00 am
Medigene ag to present at the h.c. wainwright 25th annual global investment conference
Planegg/Martinsried, September 5, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-on...
September 5, 2023, 11:00 am
Zenas biopharma announces strategic license and collaboration agreement with bristol myers squibb to develop and commercialize novel bi-functional antibody obexelimab in japan, south korea, taiwan, si
Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients aroun...
September 5, 2023, 10:00 am
Zenas biopharma announces strategic license and collaboration agreement with bristol myers squibb to develop and commercialize novel bi-functional antibody obexelimab in japan, south korea, taiwan, si
Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients aroun...
September 5, 2023, 10:00 am
Aim immunotech to present at the h.c. wainwright 25th annual global investment conference
OCALA, Fla., Sept. 05, 2023 (GLOBE NEWSWIRE) -- AIM immunoTech Inc. (NYSE American: AIM) (“AIM” or...
September 5, 2023, 9:05 am
Harpoon therapeutics to host kol event in person and via webcast on september 15, 2023
KOLs to provide insight and discussion of HPN328 targeting SCLC, NEPC and other neuroendocrine tumors Abstract with HPN328 interim data accepted for p...
September 5, 2023, 8:05 am
Cytomed therapeutics: an innovative immunology biotech company to watch
CytoMed Therapeutics is developing next-generation CAR-T cell therapies from γδ T cells for multiple solid tumor indications. The use of γδ T cell...
September 1, 2023, 8:00 pm